Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1175P is classified as a pseudogene related to U6 small nuclear RNA. While U6 snRNA molecules are functional components of the spliceosome, required for pre-mRNA splicing, pseudogenes such as RNU6-1175P are considered nonfunctional remnants of ancestral functional genes[7][3][5]. Such pseudogenes do not encode functional RNA or protein and are not recognized as therapeutic targets, nor are they implicated in biological pathways, diseases, or drug interactions. The presence of numerous U6 snRNA pseudogenes in the human genome reflects evolutionary duplication and inactivation events[3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1175, pseudogene (RNU6-1175P).